Senior living communities must consider how to rework current facilities with manageable steps to compete for both residents and employees.

It’s been a year since the gene-editing treatment Casgevy was approved for sickle cell disease and a related blood disorder.

Objective Treatment compliance among psychiatric patients is related to disease outcomes. How to assess patient compliance remains a concern. Here, we established a predictive model for medication ...

1. About lecanemab (generic name, brand name: Leqembi®) Lecanemab is the result of a strategic research alliance between Eisai and BioArctic. It is a humanized immunoglobulin gamma 1 (IgG1) monoclonal ...

Monogenic forms of early onset severe childhood obesity (ie, presenting before the age of 5 years) can occur in the context ...